Literature DB >> 25422191

Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.

Yi-Qiang Jiang1, Teng-Fei Zhong, Yi-Wu Dang, Ling-Song Zou, Liu Yang, Xia Yang, Gang Chen.   

Abstract

BACKGROUND: To explore the expression of DcR3 protein and its clinicopathological significance in bladder urothelial carcinomas (BUC).
MATERIALS AND METHODS: Immunohistochemistry was performed to detect the expression of DcR3, caspase-3, Bcl-2, VEGF, Ki-67, PCNA and P53 in 166 BUC and 56 normal bladder tissues. Western blotting was used to detect the expression of DcR3 in the supernatants of cultured BUC cells.
RESULTS: Overexpression of DcR3 was found in BUC tissues and cell lines, with significant elevation as compared to normal bladder tissues (p<0.0001). Higher DcR3 expression was related to the status of invasion, lymph node metastasis and recurrence. Furthermore, DcR3 expression was negatively correlated with caspase-3 and positively associated with Bcl-2, VEGF, Ki-67 labeling index (LI), PCNA LI and P53 (all p<0.0001), respectively.
CONCLUSIONS: DcR3 may play a crucial role as an oncogene in tumorigenesis, deterioration and progress of BUC via influencing related pathways of apoptosis, proliferation and angiogenesis. The detection of DcR3 protein in the formalin- fixed and paraffin-embedded samples could assist to predict in prognosis of BUC patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422191     DOI: 10.7314/apjcp.2014.15.21.9137

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients.

Authors:  Xin Zhang; Tengfei Zhong; Yiwu Dang; Zuyun Li; Ping Li; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT.

Authors:  Yu Zhang; Suning Huang; Yuhua Leng; Xin Chen; Tiantian Liu; Hanlin Wang; Fanglin Wei; Dianzhong Luo; Gang Chen; Zhuxin Wei
Journal:  Onco Targets Ther       Date:  2016-08-29       Impact factor: 4.147

3.  Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis.

Authors:  Chaojie Liang; Yingchen Xu; Guangming Li; Tuanjie Zhao; Feng Xia; Guanqun Li; Dongxin Zhang; Jixiang Wu
Journal:  Onco Targets Ther       Date:  2017-01-18       Impact factor: 4.147

Review 4.  Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.

Authors:  Shie-Liang Hsieh; Wan-Wan Lin
Journal:  J Biomed Sci       Date:  2017-06-19       Impact factor: 8.410

5.  DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.

Authors:  Yan-Ping Liu; Hui-Fang Zhu; Ding-Li Liu; Zhi-Yan Hu; Sheng-Nan Li; He-Ping Kan; Xiao-Yan Wang; Zu-Guo Li
Journal:  Oncotarget       Date:  2016-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.